Non-Profit Trusted Source of Non-Commercial Health Information
The Original Voice of the American Academy of Anti-Aging, Preventative, and Regenerative Medicine
logo logo

Mark Houston, M.D., MS, FACP, FAHA

Associate Clinical Professor of Medicine, Vanderbilt University School of Medicine (Tennessee, USA)



Dr. Mark C. Houston, M.D, M.S., SCH, ABAAM, FACP, FAHA graduated Phi Beta Kappa and Summa Cum Laude from Rhodes College with a BA in Chemistry and was a semifinalist as a Rhodes Scholar. He graduated with highest honors and the Alpha Omega Alpha honorary society distinction from Vanderbilt Medical School. Dr. Houston completed his medical internship and residency at the University of California, San Francisco, then returned to Vanderbilt Medical Center where he was chief resident in medicine from where he received the Hillman Award for Best Teacher. Dr. Houston remained on the full time internal medicine faculty at Vanderbilt University Medical School where he served as Medical Director of Executive Physical Program, Medical Director of the Cooperative Care Center, Co-Director of Medical Intensive Care Unit, Chief Clinical Section of the Division of General Internal Medicine and as Assistant and then Associate Professor of Medicine.

Dr. Houston is presently Associate Clinical Professor of Medicine, Vanderbilt University School of Medicine and Director of the Hypertension Institute, Vascular Biology and the Life Extension Institute, Saint Thomas Medical Group, Saint Thomas Hospital and Health Services in Nashville, Tennessee. He is also Medical Director of Clinical Research, Section Chief of the Division of Nutrition and Director of CME in the Hypertension Institute. He is staff physician of the Vascular Institute of Saint Thomas Hospital.

Dr. Houston specializes in hypertension, lipid disorders, prevention and treatment of cardiovascular diseases, nutrition, clinical age management and general internal medicine with an active clinical and research practice as well as teaching responsibilities for Vanderbilt medical students, interns and residents. He has been elected to membership in the Honor Society of AOA from Vanderbilt Medical School and Phi Kappa Phi at the University of Bridgeport, Connecticut, May 2003. He is on the Consulting Editorial Board or consulting reviewer for over 20 major U.S. medical journals, is on the Editorial Board and is Chair of the Medical Advisory Board of the American Nutraceutical Association (ANA) and Editor-in-Chief for the Journal of the American Nutraceutical Association (JANA). He is on the Board of Trust and Executive Board for the Consortium of Southeastern Hypertension Control (COSEHC).

Dr. Houston has presented over 10,000 lectures on hypertension nationally and internationally, and has published over 200 articles and scientific abstracts in peer reviewed medical journals as well as textbook chapters, handbooks, books and films and completed over 80 clinical research studies in hypertension, hyperlipidemia and cardiovascular disease. Four best selling books that he has authored are the Handbook of Antihypertensive Therapy, Vascular Biology for the Clinician, What Your Doctor May Not Tell You About Hypertension and Hypertension Handbook for Students and Clinicians and the new Hypertension Handbook, the first single authored textbook on integrative management of hypertension and cardiovascular disease, published by Wiley/Blackwell (United Kingdom).

Dr. Houston is triple boarded with board certification by the American Board of Internal Medicine , the American Society of Hypertension (ASH) as a specialist in clinical hypertension (SCH) and the American Board of Anti-Aging and Regenerative Medicine (ABAARM). He has a Masters of Science degree in Human Nutrition from the University of Bridgeport, Connecticut (2003). He is certified in skin care by AMET, the American Aesthetic Medical Educators Training (2010).

Dr. Houston was elected as a Fellow in the American College of Physicians (FACP), Fellow of the National Council on High Blood Pressure, Fellow of the American Heart Association (FAHA) and is a member of numerous medical societies including the American Heart Association, Nashville Academy of Medicine (NAM), American Medical Association (AMA), American College of Physicians (ACP), American Society of Internal Medicine (ASIM), Consortium for Southeastern Hypertension Control (COSEHC), American Society of Hypertension (ASH), National Council on High Blood Pressure (NCHBP), International Society of Hypertension (ISH), Inter-American Society of Hypertension (IASH), American Thoracic Society (ATS), Tennessee Medical Association (TMA), American Federation of Clinical Research (AFCR), International Society of Hypertension in Blacks (ISHIB), Southeastern Lipid Association (SELA), Vascular Biology Working Group (VBWG) and the AHA Council on Arteriosclerosis, Thrombosis and Vascular Biology.